TG Therapeutics Stock Guidance | NASDAQ:TGTX | Benzinga

TG Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
03/03/2025TGTX
TG Therapeutics
FY2025$540.00M$540.00M$534.45MGet Alert
01/14/2025TGTX
TG Therapeutics
FY2025$540.00M$540.00M$537.84MGet Alert

FAQ

Q

What is the most recent guidance for TG Therapeutics (TGTX)?

A

There have been no specific sales or earnings guidance reported for TG Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch